Cancer and neurologic degeneration in xeroderma pigmentosum: Long term follow-up characterises the role of DNA repair

Journal of Medical Genetics

Volumn 48, Issue 3, 2011, Pages 168-176

  Bradford, Porcia T ^a   Goldstein, Alisa M ^a   Tamura, Deborah ^a   Khan, Sikandar G ^a   Ueda, Takahiro ^a   Boyle, Jennifer ^a   Oh, Kyu Seon ^a   Imoto, Kyoko ^a   Inui, Hiroki ^a   Moriwaki, Shin Ichi ^a   Emmert, Steffen ^a   Pike, Kristen M ^b   Raziuddin, Arati ^b   Plona, Teri M ^b   DiGiovanna, John J ^a,c   Tucker, Margaret A ^a   Kraemer, Kenneth H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGE; ARTICLE; CAUSE OF DEATH; DISEASE COURSE; DNA REPAIR; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NERVE DEGENERATION; PRIORITY JOURNAL; SKIN CANCER; SUN EXPOSURE; SUNBURN; XERODERMA PIGMENTOSUM;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DNA REPAIR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MELANOMA; MIDDLE AGED; NEURODEGENERATIVE DISEASES; RECEPTOR, MELANOCORTIN, TYPE 1; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; XERODERMA PIGMENTOSUM; YOUNG ADULT;

EID: 79951785364     PISSN: 00222593     EISSN: 14686244     Source Type: Journal    
DOI: 10.1136/jmg.2010.083022     Document Type: Article

References (79)

1. Mahindra P, DiGiovanna JJ, Tamura D, Brahim JS, Hornyak TJ, Stern JB, Lee CC, Khan SG, Brooks BP, Smith JA, Driscoll BP, Montemarano AD, Sugarman K, Kraemer KH. Skin cancers, blindness, and anterior tongue mass in African brothers. J Am Acad Dermatol 2008;59:881-6.
2. Robbins JH, Brumback RA, Mendiones M, Barrett SF, Carl JR, Cho S, Denckla MB, Ganges MB, Gerber LH, Guthrie RA. Neurological disease in xeroderma pigmentosum. Documentation of a late onset type of the juvenile onset form. Brain 1991;114:1335-61.
3. Kraemer KH, Lee MM, Scotto J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis 1984;5:511-14. (Pubitemid 14126719)
4. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987;123:241-50.
5. Kraemer KH, Lee MM, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 1994;130:1018-21. (Pubitemid 24255035)
6. Robbins JH, Kraemer KH, Lutzner MA, Festoff BW, Coon HG. Xeroderma pigmentosum. An inherited disease with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med 1974;80:221-48.
7. Kraemer KH, Patronas NJ, Schiffmann R, Brooks BP, Tamura D, DiGiovanna JJ. Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: A complex genotype-phenotype relationship. Neuroscience 2007;145:1388-96. (Pubitemid 46602743)
8. Lindenbaum Y, Dickson D, Rosenbaum P, Kraemer K, Robbins I, Rapin I. Xeroderma pigmentosum/cockayne syndrome complex: first neuropathological study and review of eight other cases. Eur J Paediatr Neurol 2001;5:225-42. (Pubitemid 33077077)
9. Rapin I, Lindenbaum Y, Dickson DW, Kraemer KH, Robbins JH. Cockayne syndrome and xeroderma pigmentosum. Neurology 2000;55:1442-9.
10. Kraemer KH, Ruenger TM. Genome instability, DNA repair and cancer. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, eds. Fitzpatrick's Dermatology in General Medicine. 7th edn. New York: McGraw Hill, 2008:977-86.
11. Ruenger TM, DiGiovanna JJ, Kraemer KH. Hereditary Diseases of genome instability and DNA repair. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, eds. Fitzpatrick's Dermatology in General Medicine. 7th edn. New York: McGraw Hill, 2008:1311-25.
12. Sugasawa K. Xeroderma pigmentosum genes: functions inside and outside DNA repair. Carcinogenesis 2008;29:455-65. (Pubitemid 351418943)
13. Hanawalt PC. Controlling the efficiency of excision repair. Mutat Res 2001;485:3-13. (Pubitemid 32112777)
14. Bastiaens MT, ter Huurne JA, Kielich C, Gruis NA, Westendorp RG, Vermeer BJ, Bavinck JN. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet 2001;68:884-94. (Pubitemid 32289734)
15. Box NF, Duffy DL, Irving RE, Russell A, Chen W, Griffyths LR, Parsons PG, Green AC, Sturm RA. Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol 2001;116:224-9. (Pubitemid 32173725)
16. Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck JN. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001;117:294-300. (Pubitemid 34205714)
17. Sturm RA. Skin colour and skin cancer-MC1R, the genetic link. Melanoma Res 2002;12:405-16. (Pubitemid 35264716)
18. Goldstein AM, Landi MT, Tsang S, Fraser MC, Munroe DJ, Tucker MA. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiol Biomarkers Prev 2005;14:2208-12. (Pubitemid 41603269)
19. Broughton BC, Berneburg M, Fawcett H, Taylor EM, Arlett CF, Nardo T, Stefanini M, Menefee E, Price VH, Queille S, Sarasin A, Bohnert E, Krutmann J, Davidson R, Kraemer KH, Lehmann AR. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene. Hum Mol Genet 2001;10:2539-47. (Pubitemid 33095004)
20. Andrews AD, Barrett SF, Robbins JH. Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation. Proc Natl Acad Sci U S A 1978;75:1984-8. (Pubitemid 8337595)
21. Boyle J, Ueda T, Gonzalez V, Oh KS, Imoto K, Inui H, Busch DB, Khan SG, Tamura D, DiGiovanna JJ, Kraemer KH. Splice mutations in the XPD gene and absence of neurological symptoms. J Invest Dermatol 2006;126:79.
22. Boyle J, Ueda T, Oh KS, Imoto K, Tamura D, Jagdeo J, Khan SG, Nadem C, DiGiovanna JJ, Kraemer KH. Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy. Hum Mutat 2008;29:1194-208.
23. Christen-Zaech S, Imoto K, Khan SG, Oh KS, Tamura D, DiGiovanna JJ, Boyle J, Patronas NJ, Schiffmann R, Kraemer KH, Paller AS. Unexpected occurrence of xeroderma pigmentosum in an uncle and nephew. Arch Dermatol 2009;145:1285-91.
24. DiGiovanna JJ, Patronas N, Katz D, Abangan D, Kraemer KH. Xeroderma pigmentosum: spinal cord astrocytoma with 9-year survival after radiation and isotretinoin therapy. J Cutan Med Surg 1998;2:153-8. (Pubitemid 28266272)
25. Emmert S, Slor H, Busch DB, Batko S, Albert RB, Coleman D, Khan SG, bu-Libdeh B, DiGiovanna JJ, Cunningham BB, Lee MM, Crollick J, Inui H, Ueda T, Hedayati M, Grossman L, Shahlavi T, Cleaver JE, Kraemer KH. Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients. J Invest Dermatol 2002;118:972-82.
26. Gaspari AA, Fleisher TA, Kraemer KH. Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum. J Clin Invest 1993;92:1135-42. (Pubitemid 23273884)
27. Inui H, Oh KS, Nadem C, Ueda T, Khan SG, Metin A, Gozukara E, Emmert S, Slor H, Busch DB, Baker CC, DiGiovanna JJ, Tamura D, Seitz CS, Gratchev A, Wu WH, Chung KY, Chung HJ, Azizi E, Woodgate R, Schneider TD, Kraemer KH. Xeroderma pigmentosum-variant patients from America, Europe, and Asia. J Invest Dermatol 2008;128:2055-68.
28. Khan SG, Levy HL, Legerski R, Quackenbush E, Reardon JT, Emmert S, Sancar A, Li L, Schneider TD, Cleaver JE, Kraemer KH. Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia. J Invest Dermatol 1998;111:791-6. (Pubitemid 28509320)
29. Khan SG, Oh KS, Shahlavi T, Ueda T, Busch DB, Inui H, Emmert S, Imoto K, Muniz-Medina V, Baker CC, DiGiovanna JJ, Schmidt D, Khadavi A, Metin A, Gozukara E, Slor H, Sarasin A, Kraemer KH. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. Carcinogenesis 2006;27:84-94.
30. Khan SG, Oh KS, Emmert S, Imoto K, Tamura D, DiGiovanna JJ, Shahlavi T, Armstrong N, Baker CC, Neuburg M, Zalewski C, Brewer C, Wiggs E, Schiffmann R, Kraemer KH. XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms. DNA Repair (Amst) 2009;8:114-25.
31. Kraemer KH, Coon HG, Petinga RA, Barrett SF, Rahe AE, Robbins JH. Genetic heterogeneity in xeroderma pigmentosum: complementation groups and their relationship to DNA repair rates. Proc Natl Acad Sci U S A 1975;72:59-63.
32. Kraemer KH. Xeroderma pigmentosum. A prototype disease of environmental-genetic interaction. Arch Dermatol 1980;116:541-2.
33. Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988;318:1633-7.
34. Moriwaki S, Stefanini M, Lehmann AR, Hoeijmakers JH, Robbins JH, Rapin I, Botta E, Tanganelli B, Vermeulen W, Broughton BC, Kraemer KH. DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and cockayne syndrome resemble xeroderma pigmentosum cells. J Invest Dermatol 1996;107:647-53. (Pubitemid 26338594)
35. Oh KS, Schmidt D, Kraemer KH. A new xeroderma pigmentosum group E kindred with a R273H mutation in the DDB2 gene has features mimicking XP variant cells. J Invest Dermatol 2005;124:A81.
36. Oh KS, Khan SG, Jaspers NG, Raams A, Ueda T, Lehmann A, Friedmann PS, Emmert S, Gratchev A, Lachlan K, Lucassan A, Baker CC, Kraemer KH. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome. Hum Mutat 2006;27:1092-103.
37. Okinaka RT, Perez-Castro AV, Sena A, Laubscher K, Strniste GF, Park MS, Hernandez R, MacInnes MA, Kraemer KH. Heritable genetic alterations in a xeroderma pigmentosum group G/Cockayne syndrome pedigree. Mutat Res 1997;385:107-14. (Pubitemid 28026800)
38. Quackenbush EJ, Kraemer KH, Gahl WA, Schirch V, Whiteman DA, Levine K, Levy HL. Hypoglycinaemia and psychomotor delay in a child with xeroderma pigmentosum. J Inherit Metab Dis 1999;22:915-24.
39. Rao T, DiGiovanna JJ, Tamura D, Ueda T, Boyle J, Nadem C, Oh KS, Khan SG, Patronas NJ, Schiffmann R, Brooks BP, Kraemer KH. Features of both xeroderma pigmentosum and trichothiodystrophy presenting in patients with mutations in the XPD gene. J Invest Dermatol 2007;127:S105.
40. Robbins JH, Moshell AN. DNA repair processes protect human beings from premature solar skin damage: evidence from studies on xeroderma pigmentosum. J Invest Dermatol 1979;73:102-7. (Pubitemid 10136118)
41. Robbins JH, Polinsky RJ, Moshell AN. Evidence that lack of deoxyribonucleic acid repair causes death of neurons in xeroderma pigmentosum. Ann Neurol 1983;13:682-4. (Pubitemid 13103473)
42. Robbins JH, Brumback RA, Moshell AN. Clinically asymptomatic xeroderma pigmentosum neurological disease in an adult: Evidence for a neurodegeneration in later life caused by defective DNA repair. Eur Neurol 1993;33:188-90. (Pubitemid 23099137)
43. Robbins JH, Kraemer KH, Merchant SN, Brumback RA. Adult-onset xeroderma pigmentosum neurological disease-observations in an autopsy case. Clin Neuropathol 2002;21:18-23. (Pubitemid 34098164)
44. Suzuki H, Kalair W, Shivji GM, Wang B, Toto P, Amerio P, Kraemer KH, Sauder DN. Impaired ultraviolet-B-induced cytokine induction in xeroderma pigmentosum fibroblasts. J Invest Dermatol 2001;117:1151-5. (Pubitemid 34205911)
45. Ueda T, Compe E, Catez P, Kraemer KH, Egly JM. Both XPD alleles contribute to the phenotype of compound heterozygote xeroderma pigmentosum patients. J Exp Med 2009;206:3031-46.
46. Khan SG, Yamanegi K, Zheng ZM, Boyle J, Imoto K, Oh KS, Baker CC, Gozukara E, Metin A, Kraemer KH. XPC branch-point sequence mutations disrupt U2 snRNP binding, resulting in abnormal pre-mRNA splicing in xeroderma pigmentosum patients. Hum Mutat 2010;31:167-75.
47. Imoto K, Oh KS, Boyle J, Inui H, Nadem C, Ueda T, Busch DB, Gozukara E, Khan SG, Tamura D, DiGiovanna JJ, Kraemer KH. Twelve novel mutations in 14 xeroderma pigmentosum group A families: phenotype-genotype correlation and haplotype analysis. J Invest Dermatol 2006;126:79.
48. Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA 1989;262:2097-100. (Pubitemid 20001298)
49. Ries LAG, Melbert D, Krapcho M. SEER cancer statistics review, 1975-2005. National Institutes of Health, 2010 February 25. http://seer.cancer.gov/csr/ 1975-2006.
50. Monson RR. Analysis of relative survival and proportional mortality. Comput Biomed Res 1974;7:325-32.
51. Mielke PW Jr, Berry KJ. The Terpstra-Jonckheere test for ordered alternatives: randomized probability values. Percept Mot Skills 2000;91:447-50.
52. Imoto K, Slor H, Orgal S, Khan SH, Oh KS, Busch DB, Nadem C, Ueda T, Gadoth N, Jaspers NG, Kraemer KH. Xeroderma pigmentosum group F patients with late onset neurological disease. J Invest Dermatol 2005;124:A78.
53. Hananian J, Cleaver JE. Xeroderma pigmentosum exhibiting neurological disorders and systemic lupus erythematosus. Clin Genet 1980;17:39-45. (Pubitemid 10187589)
54. Wang Y, Tan XH, DiGiovanna JJ, Richard Lee CC, Stern JB, Raffeld M, Jaffe ES, Kraemer KH. Genetic Diversity in Melanoma Metastases from a Patient with Xeroderma Pigmentosum. J Invest Dermatol 2009;130:1188-91.
55. Plotnick H. Xeroderma pigmentosum and mucocutaneous malignancies in three black siblings. Cutis 1980;25:311-13. (Pubitemid 10128836)
56. Wang Y, DiGiovanna JJ, Stern JB, Hornyak TJ, Raffeld M, Khan SG, Oh KS, Hollander MC, Dennis PA, Kraemer KH. Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. Proc Natl Acad Sci U S A 2009;106:6279-84.
57. Kraemer KH, Herlyn M, Yuspa SH, Clark WH Jr, Townsend GK, Neises GR, Hearing VJ. Reduced DNA repair in cultured melanocytes and nevus cells from a patient with xeroderma pigmentosum. Arch Dermatol 1989;125:263-8. (Pubitemid 19070216)
58. Robbins JH. Xeroderma pigmentosum. Defective DNA repair causes skin cancer and neurodegeneration. JAMA 1988;260:384-8.
59. Gerstenblith MR, Goldstein AM, Fargnoli MC, Peris K, Landi MT. Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat 2007;28:495-505. (Pubitemid 46668608)
60. Kanetsky PA, Ge F, Najarian D, Swoyer J, Panossian S, Schuchter L, Holmes R, Guerry D, Rebbeck TR. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. Cancer Epidemiol Biomarkers Prev 2004;13:808-19. (Pubitemid 38737871)
61. Savage SA, Gerstenblith MR, Goldstein AM, Mirabello L, Fargnoli MC, Peris K, Landi MT. Nucleotide diversity and population differentiation of the melanocortin 1 receptor gene, MC1R. BMC Genet 2008;9:31.
62. Cleaver JE. Defective repair replication of DNA in xeroderma pigmentosum. Nature 1968;218:652-6.
63. Giglia G, Dumaz N, Drougard C, Avril MF, ya-Grosjean L, Sarasin A. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Cancer Res 1998;58:4402-9.
64. Bivens MM, Bhosle M, Balkrishnan R, Camacho FT, Feldman SR, Fleischer AB Jr. Nonmelanoma skin cancer: is the incidence really increasing among patients younger than 40? A reexamination using 25 years of U.S. outpatient data. Dermatol Surg 2006;32:1473-9. (Pubitemid 44934896)
65. Gray DT, Suman VJ, Su WP, Clay RP, Harmsen WS, Roenigk RK. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol 1997;133:735-40.
66. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994;30:774-8. (Pubitemid 24157120)
67. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, Coldiron BM. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010;146:283-7.
68. Khan SG, Metin A, Gozukara E, Inui H, Shahlavi T, Muniz-Medina V, Baker CC, Ueda T, Aiken JR, Schneider TD, Kraemer KH. Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk. Hum Mol Genet 2004;13:343-52.
69. Rhodes LE, Gledhill K, Masoodi M, Haylett AK, Brownrigg M, Thody AJ, Tobin DJ, Nicolaou A. The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases. FASEB J 2009;23:3947-56.
70. Kennedy C, Bajdik CD, Willemze R, De Gruijl FR, Bouwes Bavinck JN. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol 2003;120:1087-93. (Pubitemid 36702922)
71. Berg RJ, Ruven HJ, Sands AT, De Gruijl FR, Mullenders LH. Defective global genome repair in XPC mice is associated with skin cancer susceptibility but not with sensitivity to UVB induced erythema and edema. J Invest Dermatol 1998;110:405-9. (Pubitemid 28158658)
72. Faustin B, Reed JC. Sunburned skin activates inflammasomes. Trends Cell Biol 2008;18:4-8.
73. Chidzonga MM, Mahomva L, Makunike-Mutasa R, Masanganise R. Xeroderma pigmentosum: a retrospective case series in Zimbabwe. J Oral Maxillofac Surg 2009;67:22-31.
74. Jacyk WK. Xeroderma pigmentosum in black South Africans. Int J Dermatol 1999;38:511-14. (Pubitemid 29331927)
75. Khatri ML, Bemghazil M, Shafi M, Machina A. Xeroderma pigmentosum in Libya. Int J Dermatol 1999;38:520-4. (Pubitemid 29331929)
76. Frazell EL, Lucas JC Jr. Cancer of the tongue. Report of the management of 1,554 patients. Cancer 1962;15:1085-99.
77. Scotto J, Fears TR, Fraumeni JF. Incidence of non-melanoma skin cancer in the United States. Bethesda, MD: U.S. Department of Health and Human Services, 1982.
78. Giglia G, Bouffet E, Jouvet A, Ohgaki H, Kleihues P, Sarasin A. Molecular analysis of glioma and skin-tumour alterations in a xeroderma-pigmentosum child. Int J Cancer 1999;81:345-50. (Pubitemid 29165191)
79. Han J, Kraft P, Colditz GA, Wong J, Hunter DJ. Melanocortin 1 receptor variants and skin cancer risk. Int J Cancer 2006;119:1976-84. (Pubitemid 44356860)